The Carlyle Group acquires Ortho-Clinical Diagnostics

The Carlyle Group acquired Ortho-Clinical Diagnostics for $4.15B, a transaction completed in June 2014, structured as Corporate carve-out from Johnson & Johnson; cash.

Ortho-Clinical Diagnostics operates in Corporate Private Equity — Healthcare / Diagnostics, is based in Raritan, New Jersey, USA. Carlyle agreed to acquire Johnson & Johnson's Ortho-Clinical Diagnostics business, a global provider of blood-screening and in-vitro diagnostics solutions, for $4.15 billion. The business generated roughly $1.9 billion of net sales in 2013. The carve-out closed on June 30, 2014.

Acquire a global diagnostics business with recurring consumables revenue and room to invest as an independent company.

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.